Top Markets
#1 DogBull DogBull +106.61%
#2 ADO Protocol ADO Protocol +51.09%
#3 Siacoin Siacoin +46.52%
#4 The Bitcoin Bull The Bitcoin Bull +39.75%
#5 MarsCoin MarsCoin +37.44%
#6 Glidr Glidr +29.43%
#7 UnifAI Network UnifAI Network +27.12%
#8 Ontology Gas Ontology Gas +25.59%
#9 Useless Coin Useless Coin +18.01%
#10 Falcon Finance Falcon Finance +17.75%
Coin of the day
DogBull DogBull
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Clover Biopharmaceuticals, Ltd. Clover Biopharmaceuticals, Ltd.

Clover Biopharmaceuticals, Ltd.

2197
Pozycja w akcjach #15713
Clover Biopharmaceuticals, Ltd. is a biotechnology enterprise focused on... Clover Biopharmaceuticals, Ltd. is a biotechnology enterprise focused on discovering, developing, and commercializing innovative vaccines and biological therapies. Their efforts target infectious diseases, various cancers, and autoimmune conditions. The company's pipeline features several key candidates: SCB-2019 (CpG 1018/Alum): A COVID-19 vaccine candidate currently advancing through Phase II/III clinical trials. SCB-313: A trimeric fusion protein aimed at treating severe intracavitary malignancies, including malignant ascites, malignant pleural effusions, and peritoneal carcinomatosis, addressing a significant global medical need. SCB-808: Undergoing pivotal Phase III clinical trials for the management of rheumatic disorders. SCB-420: An aflibercept biosimilar in preclinical development for ophthalmologic conditions like wet age-related macular degeneration. SCB-219: A novel TPOR agonist in preclinical stages for the treatment of chemotherapy-induced thrombocytopenia and immune thrombocytopenic purpura. Clover also holds a collaboration and supply agreement with Dynavax, which provides its CpG 1018 adjuvant for use in preclinical studies. The company was established in 2007 and is based in Shanghai, China.
Cena akcji
$0.25841098
Kapitalizacja rynkowa
$335.38M
Zmiana (1 dzień)
-2.42%
Zmiana (1 rok)
73.70%
Kraj
CN
Handel Clover Biopharmaceuticals, Ltd. (2197)

Kategoria

Healthcare
Historia dywidend dla Clover Biopharmaceuticals, Ltd. (2197)
Clover Biopharmaceuticals, Ltd. (symbol giełdowy: 2197) wypłaciła łącznie 0 dywidend.
Suma wszystkich dywidend (skorygowana o podziały akcji): 0.00
Wskaźnik dywidendy (TTM): 0
Wypłaty dywidend dla Clover Biopharmaceuticals, Ltd. (2197) od 2026 do 2026
Roczne wypłaty dywidend
Rok Dywidenda (skorygowana o podziały akcji) Zmień
Za mało danych dla podanych dat.
Lista wszystkich wypłat dywidend
Rok Dywidenda Zmień
Za mało danych dla podanych dat.
Wypłaty dywidend firm podobnych lub konkurencyjnych
Firma Liczba wypłat dywidend Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH